CelLBxHealth (FRA:DWV) ROC %: -145.24% (As of Dec. 2025)

What is CelLBxHealth ROC %?

CelLBxHealth FRA:DWV -8.11% ROC % is -145.24% as of Dec. 2025. The stock has 5 warning signs investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. CelLBxHealth's annualized return on capital (ROC %) for the quarter that ended in Dec. 2025 was -145.24%.

As of today (2026-06-26), CelLBxHealth's WACC % is 16.49%. CelLBxHealth's ROC % is -157.08% (calculated using TTM income statement data). CelLBxHealth earns returns that do not match up to its cost of capital. It will destroy value as it grows.

CelLBxHealth (FRA:DWV) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, CelLBxHealth's WACC % is 16.49%. CelLBxHealth's ROC % is -157.08% (calculated using TTM income statement data). CelLBxHealth earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

CelLBxHealth ROC % Related Terms

CelLBxHealth ROC % Historical Data

* Premium members only.

The historical data trend for CelLBxHealth's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CelLBxHealth ROC % Chart

CelLBxHealth Annual Data

Trend

Apr16

Apr17

Apr18

Apr19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROC %

Get a 7-Day Free Trial

-138.18

-157.68

-130.58

-108.59

-157.27

CelLBxHealth Semi-Annual Data
	Apr16	Oct16	Apr17	Oct17	Apr18	Oct18	Apr19	Oct19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
ROC %	Get a 7-Day Free Trial															-128.10	-124.19	-108.63	-147.81	-145.24

CelLBxHealth ROC % Calculation

CelLBxHealth's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2025 is calculated as:

	ROC % (A: Dec. 2025 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (A: Dec. 2024 )	+	Invested Capital (A: Dec. 2025 ))	/ count )
=	-17.608 * ( 1 - 0% )	/	( (16.852	+	5.54)	/ 2 )
=	-17.608	/	11.196
=	-157.27 %

where

	Invested Capital		(A: Dec. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	30.736	-	1.298	-	( 12.586	-	max(0, 3.933	-	19.81	+	12.586	))
=	16.852

	Invested Capital		(A: Dec. 2025 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	14.387	-	1.28	-	( 8.402	-	max(0, 4.31	-	11.877	+	8.402	))
=	5.54

CelLBxHealth's annualized Return on Capital (ROC %) for the quarter that ended in Dec. 2025 is calculated as:

	ROC % (Q: Dec. 2025 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2025 )	+	Invested Capital (Q: Dec. 2025 ))	/ count )
=	-13.09 * ( 1 - 0% )	/	( (12.485	+	5.54)	/ 2 )
=	-13.09	/	9.0125
=	-145.24 %

where

	Invested Capital		(Q: Jun. 2025 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	21.274	-	2.589	-	( 6.2	-	max(0, 3.706	-	11.609	+	6.2	))
=	12.485

	Invested Capital		(Q: Dec. 2025 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	14.387	-	1.28	-	( 8.402	-	max(0, 4.31	-	11.877	+	8.402	))
=	5.54

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data. The tax rate is limited to between 0% and 100%.

Frequently Asked Questions Learn more about ROC % →

What does a ROC % of -145.24% mean?

CelLBxHealth (FRA:DWV) has a ROC % of -145.24% as of Dec. 2025. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on CelLBxHealth and its competitors.

Is CelLBxHealth's ROC % too high?

CelLBxHealth's current ROC % is -145.24%.

How does CelLBxHealth's ROC % compare to TMO and DHR?

CelLBxHealth's ROC % of -145.24% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROC % for a Medical Diagnostics & Research company?

A good ROC % depends on the Medical Diagnostics & Research industry context. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROC % mean?

A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on CelLBxHealth and its competitors. CelLBxHealth's current ROC % is -145.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is CelLBxHealth stock overvalued right now?

CelLBxHealth (FRA:DWV) has a current ROC % of -145.24%. The current ROC % is -145.24%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROC % calculated?

ROC % is calculated from a company's financial statements. For CelLBxHealth (FRA:DWV), the current ROC % is -145.24% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CelLBxHealth Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies LSE:ABDX LSE:HVO LSE:GDR LSE:OBD LSE:GENI LSE:VRCI LSE:PRM TMO DHR SHSE:603259 XSWX:LONN IDXX A WAT NTRA IQV ILMN MTD DGX LH

Other Exchanges ANPCF:USA CLBX:UK

Address 10 Nugent Road, The Surrey Research Park, Surrey, Guildford, GBR, GU2 7AF

Website https://www.angleplc.com

CelLBxHealth PLC is active in the healthcare sector in the United Kingdom. The Company's principal trading activity is undertaken in relation to the development and commercialization of the Parsortix cell separation system, with deployment in liquid biopsy that is non-invasive cancer diagnostics. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology can potentially treat and diagnose various forms of cancer. The Parsortix system can capture and harvest CTCs from patient blood. Its geographical segments include Europe and North America, of which the majority of its revenue is generated from Europe.